US › Healthcare

Abivax SA American Depositary Shares (ABVX)

US · Healthcare · Biotechnology

$125.19+0.33%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-48.5M
Profit YoY
+7.5%
EPS
$-0.71
EPS estimate
$-0.81

EPS came in at -0.71 against a street estimate of -0.81 — a beat of 12.3%.

Key statistics

Market cap
$10.89B
Forward P/E
0.0
P/B
22.09
Book value
$6.24
EPS (TTM)
$-5.31
52-week high
$148.83
52-week low
$67.09
50-day MA
$118.54
200-day MA
$116.83
Beta
-0.21

Analyst view

Analysts rate Abivax SA American Depositary Shares a buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $165.91.

Shareholding

Institutions
71.26%

Largest institutional holders

FundStake
TCG Crossover Management, LLC7.44%
UBS Group AG5.22%
Darwin Global Management, Ltd.3.98%
Morgan Stanley - Brokerage Accounts1.96%
Vestal Point Capital LP1.72%
Caligan Partners LP1.68%
ADAR1 Capital Management LLC1.60%
Westfield Capital Management Company, L.P.1.52%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Abivax SA American Depositary Shares — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.